Previous Close | 0.0800 |
Open | 0.0800 |
Bid | 0.0000 |
Ask | 0.0500 |
Strike | 5.00 |
Expire Date | 2024-05-17 |
Day's Range | 0.0800 - 0.0800 |
Contract Range | N/A |
Volume | |
Open Interest | 47 |
Despite a dip in product sales, PTN progresses in clinical developments and maintains a stable financial footing.
Q3 2024 Palatin Technologies Inc Earnings Call
Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system, today announced financial results for its fiscal third quarter ended March 31, 2024.